Poisson regression models were used to calculate the relative risks and 95% confidence intervals of acquiring cervical or vaginal cancer for women with a diagnosis of CIN3, relative to other women, by attained age and calendar time during follow-up. Diagnosis of CIN 3 was assessed as a time-varying covariate. Interaction terms between diagnosis of CIN 3 and attained age, on the one hand, and between diagnosis of CIN3 and calendar time on the other, allowed us to estimate the excess risk of women diagnosed with CIN 3 over attained age and calendar time. The logarithm of person-time of follow-up was used as the offset parameter in the regression models. We also investigated the effect of age at treatment in a model stratifying for attained age and adjusting for calendar time.
To allow for direct comparisons to the regression models with standardized incidence ratios (SIR) and standardized mortality ratios (SMR) in our main analyses, an additional restricted regression model was set up, including follow-up duration and treatment period. Women diagnosed with CIN 3 were divided into different strata depending on treatment period, while women without CIN 3 were defined as the reference group. This should be equivalent to modeling SIRs with expected number of cases as the offset.
Results
From age 55-59 and up, there was a clear increasing trend of excess relative risk of cervical or vaginal cancer for women previously diagnosed with CIN 3, compared to other women (Table 2) . In an additional model, the excess risk of cervical or vaginal cancer for women diagnosed with CIN 3 was also assessed over calendar time of follow-up. The trend in excess risk over attained age remained the same but varied with calendar time. While there was no excess risk for women diagnosed with CIN 3 during 1960-69, the excess risk was around four times that of other women during the following decades , and decreased to around 2.5 times during the last decade (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) . There was an increase in excess risk of vaginal or cervical cancer with increasing age at treatment and the risk increased with attained age above age 60 in all strata except the youngest were few women reached this age during follow-up (table 3) .
In the restricted model, including attained age, time of follow-up since diagnosis of CIN 3 and calendar time of diagnosis of CIN 3, there was a clear trend of increasing relative excess relative risk from ages 40-59 and up. There was no clear trend with calendar time of CIN 3 diagnosis, while the excess relative risk decreased with duration of follow-up since CIN 3 diagnosis (table 4) .
Conclusion
The finding in the main analysis of an increasing excess risk of cervical or vaginal cancer with increasing age for women previously diagnosed with CIN 3 was verified in all analyses based on follow-up of individual women, with person-time as the offset in the regression model. The conclusion is that the main results based modeling of SIR's are valid. Table 2 ). 
